Lapinski TW - Search Results

1

Specific ssDNA concentration in liver tissue as an index of apoptosis in hepatitis C virus-infected patients.

Lapinski TW, Panasiuk A, Jaroszewicz J, Kowalczuk O, Flisiak R, Rogalska M. Lapinski TW, et al. World J Gastroenterol. 2005 Oct 21;11(39):6130-3. doi: 10.3748/wjg.v11.i39.6130. World J Gastroenterol. 2005. PMID: 16273639 Free PMC article.

2

Serum concentration of sFas and sFasL in healthy HBsAg carriers, chronic viral hepatitis B and C patients.

Lapinski TW, Kowalczuk O, Prokopowicz D, Chyczewski L. Lapinski TW, et al. World J Gastroenterol. 2004 Dec 15;10(24):3650-3. doi: 10.3748/wjg.v10.i24.3650. World J Gastroenterol. 2004. PMID: 15534924 Free PMC article.

3

Efficiency and safety of lamivudine therapy in patients with chronic HBV infection, dialysis or after kidney transplantation.

Lapinski TW, Flisiak R, Jaroszewicz J, Michalewicz M, Kowalczuk O. Lapinski TW, et al. World J Gastroenterol. 2005 Jan 21;11(3):400-2. doi: 10.3748/wjg.v11.i3.400. World J Gastroenterol. 2005. PMID: 15637753 Free PMC article. Clinical Trial.

4

Effect of pegylated interferon alpha 2b plus ribavirin treatment on plasma transforming growth factor-beta1, metalloproteinase-1, and tissue metalloproteinase inhibitor-1 in patients with chronic hepatitis C.

Flisiak R, Jaroszewicz J, Lapinski TW, Flisiak I, Prokopowiczi D. Flisiak R, et al. Among authors: lapinski tw. World J Gastroenterol. 2005 Nov 21;11(43):6833-8. doi: 10.3748/wjg.v11.i43.6833. World J Gastroenterol. 2005. PMID: 16425392 Free PMC article.

5

Concentrations of soluble Fas and soluble Fas ligand as indicators of programmed cell death among patients coinfected with Human Immunodeficiency Virus and Hepatitis C Virus.

Lapinski TW, Jaroszewicz J, Wiercinska-Drapalo A. Lapinski TW, et al. Viral Immunol. 2006 Summer;19(3):570-5. doi: 10.1089/vim.2006.19.570. Viral Immunol. 2006. PMID: 16987075

6

Concentrations of ssDNA in liver tissue and its correlation with sFas and sFasL in serum of patients infected with HBV, HCV, HCV and HIV.

Łapinski TW, Wiercińska-Drapało A, Panasiuk A, Kovalchuk O. Łapinski TW, et al. Adv Med Sci. 2007;52:109-13. Adv Med Sci. 2007. PMID: 18217400

7

Plasma transforming growth factor beta1, metalloproteinase-1 and tissue inhibitor of metalloproteinases-1 in acute viral hepatitis type B.

Flisiak R, Jaroszewicz J, Lapiński TW, Flisiak I, Rogalska M, Prokopowicz D. Flisiak R, et al. Among authors: lapinski tw. Regul Pept. 2005 Nov;131(1-3):54-8. doi: 10.1016/j.regpep.2005.06.002. Regul Pept. 2005. PMID: 16081167

8

Does HAART improve renal function? An association between serum cystatin C concentration, HIV viral load and HAART duration.

Jaroszewicz J, Wiercinska-Drapalo A, Lapinski TW, Prokopowicz D, Rogalska M, Parfieniuk A. Jaroszewicz J, et al. Among authors: lapinski tw. Antivir Ther. 2006;11(5):641-5. Antivir Ther. 2006. PMID: 16964834

9

Epidemiological features of patients infected with HCV genotype 4 in Poland: Epidemiology of HCV genotype 4 in Poland.

Chlabicz S, Flisiak R, Lapinski TW, Kowalczuk O, Wiercinska-Drapalo A, Pytel-Krolczuk B, Grzeszczuk A, Chyczewski L, Pancewicz J. Chlabicz S, et al. Among authors: lapinski tw. Hepat Mon. 2011 Mar;11(3):191-4. Hepat Mon. 2011. PMID: 22087142 Free PMC article.

10

Serum cytochrome c and m30-neoepitope of cytokeratin-18 in chronic hepatitis C.

Parfieniuk-Kowerda A, Lapinski TW, Rogalska-Plonska M, Swiderska M, Panasiuk A, Jaroszewicz J, Flisiak R. Parfieniuk-Kowerda A, et al. Among authors: lapinski tw. Liver Int. 2014 Apr;34(4):544-50. doi: 10.1111/liv.12297. Epub 2013 Aug 28. Liver Int. 2014. PMID: 23981197

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

102 results

Search Page

Filters